An evaluation of Ibrutinib for the treatment of Waldenstrom macroglobulinaemia
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1770727
Abstract: ABSTRACT Introduction Waldenstrom Macroglobulinaemia (WM) is a heterogenous condition which poses a challenge to manage. Novel therapies such as Ibrutinib have been shown to be efficacious in treating WM. The landscape of Ibrutinib’s role in… read more here.
Keywords: ibrutinib; ibrutinib treatment; waldenstrom macroglobulinaemia; evaluation ibrutinib ... See more keywords